Sanofi inks an alliance pact with chronic disease-focused digital therapeutics player

Over the past few years, the digital health space has been rapidly expanding and drawing the attention of Big Pharma. Now, one company has grabbed Sanofi’s attention — and sealed a deal.

New-York based DarioHealth announced it entered into a strategic alliance agreement with Sanofi’s US subsidiary in a multi-year, $30 million deal. The agreement will push Dario’s “digital therapeutics” market expansion and commercial adoption, the company said in a statement.